Your browser doesn't support javascript.
loading
COSPAR Sample Safety Assessment Framework (SSAF).
Kminek, Gerhard; Benardini, James N; Brenker, Frank E; Brooks, Timothy; Burton, Aaron S; Dhaniyala, Suresh; Dworkin, Jason P; Fortman, Jeffrey L; Glamoclija, Mihaela; Grady, Monica M; Graham, Heather V; Haruyama, Junichi; Kieft, Thomas L; Koopmans, Marion; McCubbin, Francis M; Meyer, Michael A; Mustin, Christian; Onstott, Tullis C; Pearce, Neil; Pratt, Lisa M; Sephton, Mark A; Siljeström, Sandra; Sugahara, Haruna; Suzuki, Shino; Suzuki, Yohey; van Zuilen, Mark; Viso, Michel.
Afiliação
  • Kminek G; European Space Agency, Mars Exploration Group, Noordwijk, The Netherlands.
  • Benardini JN; NASA Headquarters, Office of Planetary Protection, Washington, DC, USA.
  • Brenker FE; Goethe University, Department of Geoscience, Frankfurt, Germany.
  • Brooks T; UK Health Security Agency, Rare & Imported Pathogens Laboratory, Salisbury, UK.
  • Burton AS; NASA Johnson Space Center, Astromaterials Research and Exploration Science Division, Houston, Texas, USA.
  • Dhaniyala S; Clarkson University, Department of Mechanical and Aeronautical Engineering, Potsdam, New York, USA.
  • Dworkin JP; NASA Goddard Space Flight Center, Solar System Exploration Division, Greenbelt, Maryland, USA.
  • Fortman JL; Security Programs, Engineering Biology Research Consortium, Emeryville, USA.
  • Glamoclija M; Rutgers University, Department of Earth and Environmental Sciences, Newark, New Jersey, USA.
  • Grady MM; The Open University, Faculty of Science, Technology, Engineering & Mathematics, Milton Keynes, UK.
  • Graham HV; NASA Goddard Space Flight Center, Astrochemistry Laboratory, Greenbelt, Maryland, USA.
  • Haruyama J; Japan Aerospace Exploration Agency (JAXA), Institute of Space and Astronautical Science (ISAS), Chofu, Tokyo, Japan.
  • Kieft TL; New Mexico Institute of Mining and Technology, Biology Department, Socorro, New Mexico, USA.
  • Koopmans M; Erasmus University Medical Centre, Department of Viroscience, Rotterdam, The Netherlands.
  • McCubbin FM; NASA Johnson Space Center, Astromaterials Research and Exploration Science Division, Houston, Texas, USA.
  • Meyer MA; NASA Headquarters, Planetary Science Division, Washington, DC, USA.
  • Mustin C; Centre National d'Études Spatiales (CNES), Nancy, France.
  • Onstott TC; Princeton University, Department of Geosciences, Princeton, New Jersey, USA.
  • Pearce N; London School of Hygiene & Tropical Medicine, Department of Medical Statistics, London, UK.
  • Pratt LM; Indiana University Bloomington, Earth and Atmospheric Sciences, Emeritus, Bloomington, Indiana, USA.
  • Sephton MA; Imperial College London, Department of Earth Science & Engineering, London, UK.
  • Siljeström S; RISE, Research Institutes of Sweden, Department of Methodology, Textiles and Medical Technology, Stockholm, Sweden.
  • Sugahara H; Japan Aerospace Exploration Agency (JAXA), Institute of Space and Astronautical Science, Sagamihara Kanagawa, Japan.
  • Suzuki S; Japan Aerospace Exploration Agency (JAXA), Institute of Space and Astronautical Science, Sagamihara Kanagawa, Japan.
  • Suzuki Y; University of Tokyo, Graduate School of Science, Tokyo, Japan.
  • van Zuilen M; Université de Paris, Institut de Physique du Globe de Paris, Paris, France.
  • Viso M; European Institute for Marine Studies (IUEM), CNRS-UMR6538 Laboratoire Geo-Ocean, Plouzané, France.
Astrobiology ; 22(S1): S186-S216, 2022 06.
Article em En | MEDLINE | ID: mdl-35653292
ABSTRACT
The Committee on Space Research (COSPAR) Sample Safety Assessment Framework (SSAF) has been developed by a COSPAR appointed Working Group. The objective of the sample safety assessment would be to evaluate whether samples returned from Mars could be harmful for Earth's systems (e.g., environment, biosphere, geochemical cycles). During the Working Group's deliberations, it became clear that a comprehensive assessment to predict the effects of introducing life in new environments or ecologies is difficult and practically impossible, even for terrestrial life and certainly more so for unknown extraterrestrial life. To manage expectations, the scope of the SSAF was adjusted to evaluate only whether the presence of martian life can be excluded in samples returned from Mars. If the presence of martian life cannot be excluded, a Hold & Critical Review must be established to evaluate the risk management measures and decide on the next steps. The SSAF starts from a positive hypothesis (there is martian life in the samples), which is complementary to the null-hypothesis (there is no martian life in the samples) typically used for science. Testing the positive hypothesis includes four elements (1) Bayesian statistics, (2) subsampling strategy, (3) test sequence, and (4) decision criteria. The test sequence capability covers self-replicating and non-self-replicating biology and biologically active molecules. Most of the investigations associated with the SSAF would need to be carried out within biological containment. The SSAF is described in sufficient detail to support planning activities for a Sample Receiving Facility (SRF) and for preparing science announcements, while at the same time acknowledging that further work is required before a detailed Sample Safety Assessment Protocol (SSAP) can be developed. The three major open issues to be addressed to optimize and implement the SSAF are (1) setting a value for the level of assurance to effectively exclude the presence of martian life in the samples, (2) carrying out an analogue test program, and (3) acquiring relevant contamination knowledge from all Mars Sample Return (MSR) flight and ground elements. Although the SSAF was developed specifically for assessing samples from Mars in the context of the currently planned NASA-ESA MSR Campaign, this framework and the basic safety approach are applicable to any other Mars sample return mission concept, with minor adjustments in the execution part related to the specific nature of the samples to be returned. The SSAF is also considered a sound basis for other COSPAR Planetary Protection Category V, restricted Earth return missions beyond Mars. It is anticipated that the SSAF will be subject to future review by the various MSR stakeholders.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Voo Espacial / Marte Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Astrobiology Assunto da revista: BIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Voo Espacial / Marte Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Astrobiology Assunto da revista: BIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda